FIELD: physics; measurement.
SUBSTANCE: invention refers to materials research or analysis using optical facilities and can be used for experimental analysis of blood and its components (cells). Tester contains optically transparent cell with magnetic stirrer mounted in thermostating unit, laser module illuminating the cell, and gauging unit recording light scattering intensity with at least one scattered optical radiation detector. Optical axis of laser module and normal line to sensitive land of optical radiation detector make minimum angle, sufficient to prevent optical radiant flux passing through the sample cell from light-sensitive land of detector.
EFFECT: improved sensitivity and reliability of testing.
7 cl, 3 dwg
Title | Year | Author | Number |
---|---|---|---|
DEVICE TO ANALYSE BIOLOGICAL FLUID | 2012 |
|
RU2500999C2 |
DEVICE FOR DETERMINING PLATE AGGREGATION ACTIVITY | 2020 |
|
RU2749767C1 |
APPARATUS AND METHOD FOR EXPRESS ESTIMATION OF AGGREGATIVE ACTIVITY OF FORMED ELEMENTS OF BLOOD | 2020 |
|
RU2750839C1 |
METHOD OF DETERMINING AGREGATIVE ACTIVITY OF PLATELETS AND DEVICE FOR ITS REALISATION | 2008 |
|
RU2391665C1 |
METHOD OF DETERMINATION OF AGGREGATION CAPABILITIES OF THROMBOCYTES | 1988 |
|
RU1720386C |
METHOD FOR DETERMINING ASPIRIN RESISTANCE | 2019 |
|
RU2700000C1 |
METHOD FOR THROMBOCYTE AGGREGATION ACTIVITY DETERMINATION FOR PATIENTS WITH ACUTE CORONARY SYNDROME | 2016 |
|
RU2619858C1 |
METHOD OF EXAMINATION OF INTRAVASCULAR PLATELET AGGREGATION IN VITRO | 1996 |
|
RU2102754C1 |
DEVICE FOR EXAMINING PLATELETS AGGREGATION PROCESS | 1989 |
|
RU2061952C1 |
METHOD FOR DETERMINING INDIVIDUAL SENSITIVITY TO NIFEDIPIN IN CARDIOVASCULAR PATIENTS | 0 |
|
SU1786437A1 |
Authors
Dates
2009-01-10—Published
2007-06-18—Filed